MoneyWorks4Me

Sequent Scientific board to consider audited financial results

06 May 2019 Evaluate

Sequent Scientific has informed that the meeting of the Board of Directors of the Company is scheduled on 14/05/2019, to consider and approve the audited financial results of the Company for the financial year ended March 31, 2019 and declaration of dividend, if any, for the year 2018-19.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..